Large-Dose Glucocorticoid Induced Secondary Adrenal Insufficiency in Spinal Cord Injury
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective To investigate the incidence of adrenal insufficiency (AI) in patients with spinal cord injury (SCI) with symptoms similar to those of AI and to assess the relevance of AI and large-dose glucocorticoids in SCI.Methods The medical records of 228 patients who were admitted to the rehabilitation center after SCI from January 2014 to January 2016 were reviewed retrospectively. Twenty-nine of 228 patients had persistent symptoms suspicious for AI despite continuous care for more than 4 weeks. Therefore, adrenocorticotropic hormone (ACTH) stimulation tests were conducted in these 29 patients.Results Twelve of these 29 patients (41.4%) with SCI who manifested AI-like symptoms were diagnosed as having AI. Among these 29 patients, 15 patients had a history of large- dose glucocorticoid treatment use and the other 14 patients did not have such a history. Ten of the 15 patients (66.7%) with SCI treated with large-dose glucocorticoids after injury were diagnosed as having AI. In 12 patients with AI, the most frequent symptom was fatigue (66%), followed by orthostatic dizziness (50%), and anorexia (25%). In the chi-square test, the presence of AI was positively correlated with large-dose glucocorticoid use (p=0.008, Fisher exact test).Conclusion Among the patients with SCI who manifested similar symptoms as those of AI, high incidence of AI was found especially in those who were treated with large-dose glucocorticoids. During management of SCI, if a patient has similar symptoms as those of AI, clinicians should consider the possibility of AI, especially when the patient has a history of large-dose glucocorticoid use. Early recognition and treatment of the underlying AI should be performed.
Abstract
Objective To investigate the incidence of adrenal insufficiency (AI) in patients with spinal cord injury (SCI) with symptoms similar to those of AI and to assess the relevance of AI and large-dose glucocorticoids in SCI.Methods The medical records of 228 patients who were admitted to the rehabilitation center after SCI from January 2014 to January 2016 were reviewed retrospectively. Twenty-nine of 228 patients had persistent symptoms suspicious for AI despite continuous care for more than 4 weeks. Therefore, adrenocorticotropic hormone (ACTH) stimulation tests were conducted in these 29 patients.Results Twelve of these 29 patients (41.4%) with SCI who manifested AI-like symptoms were diagnosed as having AI. Among these 29 patients, 15 patients had a history of large- dose glucocorticoid treatment use and the other 14 patients did not have such a history. Ten of the 15 patients (66.7%) with SCI treated with large-dose glucocorticoids after injury were diagnosed as having AI. In 12 patients with AI, the most frequent symptom was fatigue (66%), followed by orthostatic dizziness (50%), and anorexia (25%). In the chi-square test, the presence of AI was positively correlated with large-dose glucocorticoid use (p=0.008, Fisher exact test).Conclusion Among the patients with SCI who manifested similar symptoms as those of AI, high incidence of AI was found especially in those who were treated with large-dose glucocorticoids. During management of SCI, if a patient has similar symptoms as those of AI, clinicians should consider the possibility of AI, especially when the patient has a history of large-dose glucocorticoid use. Early recognition and treatment of the underlying AI should be performed.
참고문헌 (24)
- Garcia-Zozaya IA, "Adrenal insufficiency in acute spinal cord injury", J Spinal Cord Med, 29, pp.67~69 (2006)
- Bracken MB, "Efficacy of methylprednisolone in acute spinal cord injury", JAMA, 251, pp.45~52 (1984)
- Hawryluk GW, "Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury", Neurosurg Focus, 25, pp.E14~ (2008)
- Mortimer KJ, "Oral and inhaled corticosteroids and adrenal insufficiency: a case-control study", Thorax, 61, pp.405~408 (2006)
- Shulman DI, "Adrenal insufficiency:still a cause of morbidity and death in childhood", Pediatrics, 119, pp.e484~494 (2007)
- Crowley RK, "Central hypoadrenalism", J Clin Endocrinol Metab, 99, pp.4027~4036 (2014)
- Bornstein SR, "Dissociation of ACTH and glucocorticoids", Trends Endocrinol Metab, 19, pp.175~180 (2008)
- Pastrana EA, "Acute adrenal insufficiency in cervical spinal cord injury", World Neurosurg, 77, pp.561~563 (2012)
- Cryer PE, "Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline", J Clin Endocrinol Metab, 94, pp.709~728 (2009)
- Sesso HD, "Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in men", Hypertension, 36, pp.801~807 (2000)
- Field JM, "American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care science", Circulation, 122(Suppl 3), pp.S639~S946 (2010)
- Logan IC, "Efficacy of treatments for orthostatic hypotension: a systematic review", Age Ageing, 41, pp.587~594 (2012)
- Reynolds RM, "Disorders of sodium balance", BMJ, 332, pp.702~705 (2006)
- Hurlbert RJ, "Methylprednisolone for acute spinal cord injury: an inappropriate standard of care", J Neurosurg, 93(1 Suppl), pp.1~7 (2000)
- Bydon M, "The current role of steroids in acute spinal cord injury", World Neurosurg, 82, pp.848~854 (2014)
- elkers, "Adrenal insufficiency", N Engl J Med, 335, pp.1206~1212 (1996)
- -Friedman D, "Adrenal function in sepsis: the retrospective CORTICUS cohort study", Crit Care Med, 35, pp.1012~1018 (2007)
- Huang TS, "Impaired hypothalamus-pituitary-adrenal axis in men with spinal cord injuries", Am J Phys Med Rehabil, 77, pp.108~112 (1998)
- Zeitzer JM, "Absence of detectable melatonin and preservation of cortisol and thyrotropin rhythms in tetraplegia", J Clin Endocrinol Metab, 85, pp.2189~2196 (2000)
- Bracken MB, "A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the second National Acute Spinal Cord Injury Study", N Engl J Med, 322, pp.1405~1411 (1990)
- Bracken MB, "Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study", J Neurosurg, 76, pp.23~31 (1992)
- Bracken MB, "Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the third National Acute Spinal Cord Injury randomized controlled trial. National Acute Spinal Cord Injury Study", JAMA, 277, pp.1597~1604 (1997)
- Bracken MB, "Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial", J Neurosurg, 89, pp.699~706 (1998)
- Omori N, "Spontaneous cervical epidural hematoma treated by the combination of surgical evacuation and steroid pulse therapy", Intern Med, 47, pp.437~440 (2008)